Home » Novartis Wins Patent Case for Generic Famvir
Novartis Wins Patent Case for Generic Famvir
November 25, 2009
Novartis has won a patent dispute in a district court with Teva Pharmaceutical Industries over the antiviral drug Famvir, which could make Teva liable
for damages due to its short-lived at-risk 2007 launch of a generic version.